Therapeutic role of JAK inhibitors in hepatogastrointestinal diseases
Artículo
Acceso abierto
Artículo
DOAJ
Janus kinase (JAK) inhibitors represent a major advancement in the management of immune-mediated inflammatory diseases. A balanced approach that carefully weighs therapeutic benefits against potential risks is essential....
LCC LCC:Diseases of the digestive system. GastroenterologyIdioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access